Book value compounding
Net worth compounded at 13.5% a year over 4 years (₹51,314 → ₹85,054).
Importance 54 / 95 · financial health
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Net worth compounded at 13.5% a year over 4 years (₹51,314 → ₹85,054).
Importance 54 / 95 · financial health
Trades at 5.19× earnings — 48% below the financial institution median of 10.02×.
Importance 51 / 95 · valuation
Over 4 years profit compounded at 12.9% a year while the stock fell 4.2% a year — the FY2022 base was somewhat depressed, so part of this is recovery rather than trend.
Importance 51 / 95 · business vs stock
Classified by the exchange under Financial Services › Financial Services › Finance › Financial Institution.
Peer set used on this page: 4 financial institution.
Revenue grew 11.0% a year over 4 years, from ₹39,269 cr in FY2022 to ₹59,584 cr in FY2026. Net profit grew 12.9% a year over the same period.
Revenue has compounded at 11.0% a year over 4 years (₹39,269 → ₹59,584) — steady rather than rapid.
Rule REVENUE_COMPOUNDED_MODERATE
In Q2 FY27 (Jul–Sep 2026), revenue was ₹15,000 cr (down 1.0% on the same quarter last year) and net profit ₹3,478 cr (down 21.2%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 EBITDA margin was 92.8%, down 4.13 percentage points from 96.9% a year earlier.
Rule QTR_MARGIN_CHANGED_YOY
Q2 FY27 net profit was ₹3,478 cr, down 21.2% from ₹4,415 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 net profit declined 21.2% while revenue declined 1.0% vs the same quarter last year — a gap of 20.2 percentage points.
Rule QTR_PROFIT_VS_REVENUE_GROWTH
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 14,272 | +18.4% | 4,076 | +23.2% | 28.6% |
| Q4 FY25 | 15,334 | +21.0% | 4,310 | +5.7% | 28.1% |
| Q1 FY26 | 14,737 | +12.7% | 4,466 | +29.1% | 30.3% |
| Q2 FY26 | 15,153 | +10.7% | 4,415 | +9.3% | 29.1% |
| Q3 FY26 | 15,018 | +5.2% | 4,052 | −0.6% | 27.0% |
| Q4 FY26 | 14,564 | −5.0% | 3,375 | −21.7% | 23.2% |
| Q1 FY27 | 14,435 | −2.1% | 4,193 | −6.1% | 29.0% |
| Q2 FY27 | 15,000 | −1.0% | 3,478 | −21.2% | 23.2% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
Net margin was 27.3% in FY2026 (25.5% in FY2022); ROE 20.0%; ROA 2.6%.
Margin and return trends are shown above.
Net worth was ₹85,054 cr in FY2026.
Net worth compounded at 13.5% a year over 4 years (₹51,314 → ₹85,054).
Rule NET_WORTH_COMPOUNDING
Within its 4-company Financial Institution peer group, it ranks 2 of 4 on return on equity and 3 of 4 on revenue growth. Its P/E of 5.2 compares with a peer median of 10.0.
Ranked against 4 financial institution (FY2026, consolidated).
RECLTD · 3rd of 4 · set median 7.1%
RECLTD · 3rd of 4 · set median 96.5%
RECLTD · 2nd of 4 · set median 17.8%
RECLTD · 2nd of 4 · set median 10.0×
Trades at 5.19× earnings — 48% below the financial institution median of 10.02×.
Rule PE_BELOW_PEERS
On the trailing twelve months. Last full year: P/E 4.8× · P/S 1.3× · ROE 20.0%.
The share price is down 17.6% over 1 year, down 12.2% over 3 years (−4.2% a year) and up 191% over 5 years (23.9% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 22.7% below its 52-week high.
Over 4 years profit compounded at 12.9% a year while the stock fell 4.2% a year — the FY2022 base was somewhat depressed, so part of this is recovery rather than trend.
Rule STOCK_LAGGED_EARNINGS · rebound
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 39,269 | 39,478 | 47,505 | 56,367 | 59,584 |
| Total income | 39,339 | 39,520 | 47,571 | 56,434 | 59,628 |
| EBITDA | 34,512 | 37,655 | 47,932 | 54,273 | 57,050 |
| Profit before tax | 12,442 | 13,898 | 17,960 | 20,117 | 20,766 |
| Net profit | 10,036 | 11,167 | 14,145 | 15,884 | 16,308 |
| EPS (₹) | 50.8 | 42.3 | 53.6 | 60.2 | 61.8 |
| Net worth | 51,314 | 58,121 | 69,350 | 78,376 | 85,054 |
| Operating cash flow | −3,910 | −37,360 | −57,723 | −39,101 | 5,972 |
| Free cash flow | −3,931 | −37,373 | −57,755 | −39,182 | 5,896 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | 0.5 | 20.3 | 18.7 | 5.7 |
| Profit growth YoY | — | 11.3 | 26.7 | 12.3 | 2.7 |
| Profitability | |||||
| EBITDA margin % | 87.9 | 95.4 | 100.9 | 96.3 | 95.7 |
| Net margin % | 25.5 | 28.3 | 29.7 | 28.1 | 27.3 |
| Return on equity % | 19.6 | 20.4 | 22.2 | 21.5 | 20.0 |
| Return on capital % | — | — | — | — | — |
| Leverage & cash | |||||
| Debt to equity | — | — | — | — | — |
| Cash flow ÷ profit | -0.39 | -3.35 | -4.08 | -2.46 | 0.37 |
| Current ratio | — | — | — | — | — |